Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- D. Boral Capital analyst Jason Kolbert initiated coverage on NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) with a Buy rating and announced a price target of $14. NeuroSense Therapeutics shares closed at …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- D. Boral Capital analyst Jason Kolbert initiated coverage on NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) with a Buy rating and announced a price target of $14. NeuroSense Therapeutics shares closed at …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
D. Boral Capital analyst Jason Kolbert initiated coverage on NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) with a Buy rating and announced a price target of $14. NeuroSense Therapeutics shares closed at …Full story available on Benzinga.com Read MoreFRST, News, NRSN, PMN, Top Initiations, Initiation, Markets, Analyst Ratings, Trading Ideas, FRST, PMN, NRSN, News, Initiation, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
